Literature DB >> 19245661

Enriched environment protects the nigrostriatal dopaminergic system and induces astroglial reaction in the 6-OHDA rat model of Parkinson's disease.

Agustín Anastasía1, Luciana Torre, Gabriel A de Erausquin, Daniel H Mascó.   

Abstract

Enriched environment (EE) is neuroprotective in several animal models of neurodegeneration. It stimulates the expression of trophic factors and modifies the astrocyte cell population which has been said to exert neuroprotective effects. We have investigated the effects of EE on 6-hydroxydopamine (6-OHDA)-induced neuronal death after unilateral administration to the medial forebrain bundle, which reaches 85-95% of dopaminergic neurons in the substantia nigra after 3 weeks. Continuous exposure to EE 3 weeks before and after 6-OHDA injection prevents neuronal death (assessed by tyrosine hydroxylase staining), protects the nigrostriatal pathway (assessed by Fluorogold retrograde labeling) and reduces motor impairment. Four days after 6-OHDA injection, EE was associated with a marked increase in glial fibrillary acidic protein staining and prevented neuronal death (assessed by Fluoro Jade-B) but not partial loss of tyrosine hydroxylase staining in the anterior substantia nigra. These results robustly demonstrate that EE preserves the entire nigrostriatal system against 6-OHDA-induced toxicity, and suggests that an early post-lesion astrocytic reaction may participate in the neuroprotective mechanism.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19245661      PMCID: PMC3575174          DOI: 10.1111/j.1471-4159.2009.06001.x

Source DB:  PubMed          Journal:  J Neurochem        ISSN: 0022-3042            Impact factor:   5.372


  59 in total

Review 1.  Update in the epidemiology of Parkinson's disease.

Authors:  Alexis Elbaz; Frédéric Moisan
Journal:  Curr Opin Neurol       Date:  2008-08       Impact factor: 5.710

2.  PYM50028, a novel, orally active, nonpeptide neurotrophic factor inducer, prevents and reverses neuronal damage induced by MPP+ in mesencephalic neurons and by MPTP in a mouse model of Parkinson's disease.

Authors:  Naomi P Visanji; Antonia Orsi; Tom H Johnston; Patrick A Howson; Kimberly Dixon; Noelle Callizot; Jonathan M Brotchie; Daryl D Rees
Journal:  FASEB J       Date:  2008-03-25       Impact factor: 5.191

3.  Fibroblast growth factor-2-producing fibroblasts protect the nigrostriatal dopaminergic system from 6-hydroxydopamine.

Authors:  C W Shults; J Ray; K Tsuboi; F H Gage
Journal:  Brain Res       Date:  2000-11-17       Impact factor: 3.252

4.  Preservation of a functional nigrostriatal dopamine pathway by GDNF in the intrastriatal 6-OHDA lesion model depends on the site of administration of the trophic factor.

Authors:  D Kirik; C Rosenblad; A Björklund
Journal:  Eur J Neurosci       Date:  2000-11       Impact factor: 3.386

5.  Increased progenitor cell proliferation and astrogenesis in the partial progressive 6-hydroxydopamine model of Parkinson's disease.

Authors:  P M Aponso; R L M Faull; B Connor
Journal:  Neuroscience       Date:  2007-12-04       Impact factor: 3.590

6.  Differential astroglial activation in 6-hydroxydopamine models of Parkinson's disease.

Authors:  Jeannette Henning; Ulf Strauss; Andreas Wree; Jan Gimsa; Arndt Rolfs; Reiner Benecke; Ulrike Gimsa
Journal:  Neurosci Res       Date:  2008-09-07       Impact factor: 3.304

7.  Sex-specific behavioural effects of environmental enrichment in a transgenic mouse model of amyotrophic lateral sclerosis.

Authors:  Nathan C Stam; Jess Nithianantharajah; Monique L Howard; Julie D Atkin; Surindar S Cheema; Anthony J Hannan
Journal:  Eur J Neurosci       Date:  2008-08       Impact factor: 3.386

8.  Protection of dopaminergic neurons by electroconvulsive shock in an animal model of Parkinson's disease.

Authors:  Agustín Anastasia; Gabriel A de Erausquin; José Wojnacki; Daniel H Mascó
Journal:  J Neurochem       Date:  2007-09-13       Impact factor: 5.372

Review 9.  Glial reactions in Parkinson's disease.

Authors:  Patrick L McGeer; Edith G McGeer
Journal:  Mov Disord       Date:  2008-03-15       Impact factor: 10.338

Review 10.  Treatment of Parkinson's disease with trophic factors.

Authors:  Amie L Peterson; John G Nutt
Journal:  Neurotherapeutics       Date:  2008-04       Impact factor: 7.620

View more
  23 in total

1.  Investigation of the therapeutic potential of N-acetyl cysteine and the tools used to define nigrostriatal degeneration in vivo.

Authors:  Negin Nouraei; Lauren Zarger; Justin N Weilnau; Jimin Han; Daniel M Mason; Rehana K Leak
Journal:  Toxicol Appl Pharmacol       Date:  2016-02-12       Impact factor: 4.219

2.  Nanodelivery of Cerebrolysin and Rearing in Enriched Environment Induce Neuroprotective Effects in a Preclinical Rat Model of Parkinson's Disease.

Authors:  C Requejo; J A Ruiz-Ortega; H Cepeda; A Sharma; H S Sharma; A Ozkizilcik; R Tian; H Moessler; L Ugedo; J V Lafuente
Journal:  Mol Neurobiol       Date:  2018-01       Impact factor: 5.590

3.  Neuroprotective Effects of β-Asarone Against 6-Hydroxy Dopamine-Induced Parkinsonism via JNK/Bcl-2/Beclin-1 Pathway.

Authors:  Sheng Zhang; Xue-Hong Gui; Li-Ping Huang; Min-Zhen Deng; Ruo-Ming Fang; Xue-Hong Ke; Yu-Ping He; Ling Li; Yong-Qi Fang
Journal:  Mol Neurobiol       Date:  2014-11-18       Impact factor: 5.590

4.  Environmental enrichment does not reduce the rewarding and neurotoxic effects of methamphetamine.

Authors:  Nathalie Thiriet; Benjamin Gennequin; Virginie Lardeux; Claudia Chauvet; Mickael Decressac; Thierry Janet; Mohamed Jaber; Marcello Solinas
Journal:  Neurotox Res       Date:  2010-02-09       Impact factor: 3.911

5.  Enriched Environment Altered Aberrant Hippocampal Neurogenesis and Improved Long-Term Consequences After Temporal Lobe Epilepsy in Adult Rats.

Authors:  Xiaoqian Zhang; Tingting Liu; Zhike Zhou; Xiaopeng Mu; Chengguang Song; Ting Xiao; Mei Zhao; Chuansheng Zhao
Journal:  J Mol Neurosci       Date:  2015-05-07       Impact factor: 3.444

6.  Promoting exercise in Parkinson's disease through community-based participatory research.

Authors:  Mark A Hirsch; Sanjay S Iyer; Danielle Englert; Mohammed Sanjak
Journal:  Neurodegener Dis Manag       Date:  2011-10

7.  Effect of resveratrol and environmental enrichment on biomarkers of oxidative stress in young healthy mice.

Authors:  Mustapha Shehu Muhammad; Rabiu Abdussalam Magaji; Aliyu Mohammed; Ahmed-Sherif Isa; Mohammed Garba Magaji
Journal:  Metab Brain Dis       Date:  2016-08-15       Impact factor: 3.584

8.  Glycogen synthase kinase-3 inhibitors as potent therapeutic agents for the treatment of Parkinson disease.

Authors:  J A Morales-García; C Susín; S Alonso-Gil; D I Pérez; V Palomo; C Pérez; S Conde; A Santos; C Gil; A Martínez; A Pérez-Castillo
Journal:  ACS Chem Neurosci       Date:  2012-12-05       Impact factor: 4.418

9.  Lentivirus-mediated delivery of sonic hedgehog into the striatum stimulates neuroregeneration in a rat model of Parkinson disease.

Authors:  Yi Zhang; Weiren Dong; Suiqun Guo; Shu Zhao; Suifen He; Lihua Zhang; Yinjuan Tang; Haihong Wang
Journal:  Neurol Sci       Date:  2014-07-17       Impact factor: 3.307

Review 10.  Therapies for Parkinson's diseases: alternatives to current pharmacological interventions.

Authors:  Song Li; Jie Dong; Cheng Cheng; Weidong Le
Journal:  J Neural Transm (Vienna)       Date:  2016-08-11       Impact factor: 3.575

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.